Results 201 to 210 of about 186,413 (290)
ABSTRACT Rosuvastatin (RSV), a potent HMG‐CoA reductase inhibitor, is widely used for the management of hyperlipidemia and prevention of cardiovascular disease. Its absorption and disposition are primarily transporter‐mediated, involving intestinal absorption by OATP2B1 and efflux by BCRP; hepatic uptake by OATP1B1, OATP1B3, OATP2B1, and NTCP; and ...
Ankit Balhara +2 more
wiley +1 more source
CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems. [PDF]
Boccacci Y +3 more
europepmc +1 more source
Population Pharmacokinetic Model of Pegbing in Healthy Subjects and Chronic Hepatitis B Patients
ABSTRACT Pegbing (peginterferon alpha‐2b) is a polyethylene glycol‐modified interferon α‐2b injection that has demonstrated favorable efficacy and safety profiles in the treatment of chronic hepatitis B (CHB). This study aimed to develop a population pharmacokinetic (PopPK) model of Pegbing in both healthy subjects and CHB patients and to investigate ...
Weizhe Jian +11 more
wiley +1 more source
Characterization of blood group variants in an Omani population by comparison of whole genome sequencing and serology. [PDF]
Haffener PE +7 more
europepmc +1 more source
Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz +5 more
wiley +1 more source
Ultrasound-Triggering Carbon Monoxide Release from Rhodium Nanoparticles for Myocardial Infarction Treatment. [PDF]
Wu C +11 more
europepmc +1 more source
ABSTRACT A majority of deaths associated with air pollution are attributed to cardiovascular and heart diseases. Carbon black that represents the carbon core of particulate matter, a major component of air pollution, has been shown to result in cardiac mitochondrial dysfunction.
William E. Mullen +4 more
wiley +1 more source
Weak D phenotype in transfusion medicine and obstetrics: Challenges and opportunities. [PDF]
Sainath PB, Ramaiyan V.
europepmc +1 more source

